Abstract: The present disclosure discloses a rolling ring shrink fitting tool for rotary equipment, including a lifting frame; a movement slot is formed in a bottom surface of a top of the lifting frame; an output end of a first motor is connected with a main gear; guide rollers are embedded in a lifting seat through bearings; shrink fitting plates are two semicircular structures; lifting lugs are welded on outer sides of the shrink fitting plates; tooth rings are arranged outside the shrink fitting plates; stop rods are fixed on inner walls of the tooth rings; supporting screw rods are embedded at sunken positions on inner walls of the shrink fitting plates through bearings.

Abstract: The present disclosure discloses a rolling ring shrink fitting tool for rotary equipment, including a lifting frame; a movement slot is formed in a bottom surface of a top of the lifting frame; an output end of a first motor is connected with a main gear; guide rollers are embedded in a lifting seat through bearings; shrink fitting plates are two semicircular structures; lifting lugs are welded on outer sides of the shrink fitting plates; tooth rings are arranged outside the shrink fitting plates; stop rods are fixed on inner walls of the tooth rings; supporting screw rods are embedded at sunken positions on inner walls of the shrink fitting plates through bearings.

Abstract: The present invention is related to antibodies and their immunoreactive fragments binding to an extracellular domain of B7H3 (B7-H3) molecule and the uses thereof, particularly in the treatment of cancers. The invention particularly concerns humanized anti-B7-H3 antibodies and their antigen binding fragments capable of enhancing the activation of the immune system against cancerous cells.

Abstract: The present invention is related to anti-B7S1 (B7-H4) polypeptides including anti-B7S1 (B7-H4) antibodies and their immunoreactive fragments, chimeric antigen receptor (CAR) binding to B7S1 (B7-H4) molecule and the uses thereof, particularly in the treatment of cancers. The invention particularly concerns humanized anti-B7S1 antibodies and their antigen binding fragments capable of enhancing the activation of the immune system against diseased tissues including cancerous cells, and the genetically engineered immune cells expressing anti-B7S1 CAR used for treatment of diseases including cancers.

Abstract: The present invention provides anti-IL-25 antibodies that are directed against (human) IL-25, nucleic acids that encode such antibodies, compositions, and in particular pharmaceutical compositions that comprise such antibodies; and uses of such antibodies and compositions.

Abstract: An exemplary method for encoding an image includes receiving image data, detecting edges in the image data, selecting at least some of the detected edges, encoding the selected edges as selected edge information, down-sampling the image data, encoding the down-sampled image as down-sampled image information and multiplexing the selected edges information and the down-sampled image information. In such a method, the selected edges information and the down-sampled image information can be stored as an encoded image file. Other exemplary methods, devices, systems are also disclosed.

Abstract: An exemplary method for encoding an image includes receiving image data, detecting edges in the image data, selecting at least some of the detected edges, encoding the selected edges as selected edge information, down-sampling the image data, encoding the down-sampled image as down-sampled image information and multiplexing the selected edges information and the down-sampled image information. In such a method, the selected edges information and the down-sampled image information can be stored as an encoded image file. Other exemplary methods, devices, systems are also disclosed.